Walvax BioTech Cash Flow-to-Debt Ratio
Walvax BioTech cash flow-to-debt ratio. Walvax BioTech (300142) has a Cash Flow-to-Debt Ratio of -0.01x as of September 2025, meaning its operating cash flow of CN¥-33.52 Million could theoretically repay 0% of its total liabilities (CN¥2.31 Billion) in one year. Check total reinvestment intensity of Walvax BioTech to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Walvax BioTech (2007–2025)
Cash flow-to-debt ratio of Walvax BioTech from 2007 to 2025. Historical debt coverage capacity for Walvax BioTech across 19 annual periods. Check Walvax BioTech cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Walvax BioTech Cash Flow-to-Debt Ratio by Year (2007–2025)
Walvax BioTech cash flow-to-debt ratio by year from 2007 to 2025. Year-by-year debt coverage analysis for Walvax BioTech. For the full cash flow conversion analysis, see cash efficiency ratio of Walvax BioTech.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | CN¥494.37 Million | CN¥2.26 Billion | ▼ -32.0% |
| 2024 | 0.32x | CN¥1.04 Billion | CN¥3.22 Billion | ▲ +19.2% |
| 2023 | 0.27x | CN¥1.13 Billion | CN¥4.19 Billion | ▼ -2.2% |
| 2022 | 0.28x | CN¥1.20 Billion | CN¥4.35 Billion | ▲ +44.1% |
| 2021 | 0.19x | CN¥705.28 Million | CN¥3.68 Billion | ▲ +202.5% |
| 2020 | 0.06x | CN¥114.19 Million | CN¥1.80 Billion | ▲ +38.3% |
| 2019 | 0.05x | CN¥62.02 Million | CN¥1.35 Billion | ▲ +239.5% |
| 2018 | -0.03x | CN¥-65.23 Million | CN¥1.98 Billion | ▼ -653.0% |
| 2017 | 0.00x | CN¥-10.13 Million | CN¥2.32 Billion | ▲ +86.4% |
| 2016 | -0.03x | CN¥-89.94 Million | CN¥2.80 Billion | ▼ -49.6% |
| 2015 | -0.02x | CN¥-69.41 Million | CN¥3.23 Billion | ▲ +10.3% |
| 2014 | -0.02x | CN¥-65.93 Million | CN¥2.76 Billion | ▲ +37.2% |
| 2013 | -0.04x | CN¥-121.73 Million | CN¥3.20 Billion | ▼ -162.2% |
| 2012 | 0.06x | CN¥78.38 Million | CN¥1.28 Billion | ▼ -80.5% |
| 2011 | 0.31x | CN¥91.98 Million | CN¥293.62 Million | ▲ +57.3% |
| 2010 | 0.20x | CN¥86.71 Million | CN¥435.52 Million | ▼ -48.8% |
| 2009 | 0.39x | CN¥82.18 Million | CN¥211.43 Million | ▲ +1489.3% |
| 2008 | -0.03x | CN¥-5.69 Million | CN¥203.54 Million | ▼ -117.6% |
| 2007 | 0.16x | CN¥31.85 Million | CN¥199.86 Million | — |